Tags

Type your tag names separated by a space and hit enter

Epidemiology and medical management of stone disease.

Abstract

Recurrent stone formation in the urinary tract is a common and important problem that must be considered in daily urological practice. With a prevalence of> 10% and an expected recurrence rate of approximately 50%, stone disease has an important effect on the healthcare system. It is generally agreed that patients with uric acid/urate, cystine or infection stones always should be treated pharmacologically. For calcium stone formers the treatment should be chosen according to the severity of the disease. Recurrence in patients with calcium-stone disease can be prevented with general or specific dietary and drinking advice, and with pharmacological therapy. For idiopathic calcium stone formers the most convincing therapeutic effects have been reported with thiazide and alkaline citrate.

Links

  • FREE Publisher Full Text
  • Authors+Show Affiliations

    Department of Urology, Huddinge University Hospital and Centre for Surgical Sciences, Karolinska Institutet, Stockholm, Sweden. hans.tiselius@hs.se

    Source

    BJU international 91:8 2003 May pg 758-67

    MeSH

    Calcium Phosphates
    Humans
    Infant, Newborn
    Risk Factors
    Secondary Prevention
    Uric Acid
    Urinary Calculi

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    12709088

    Citation

    Tiselius, H-G. "Epidemiology and Medical Management of Stone Disease." BJU International, vol. 91, no. 8, 2003, pp. 758-67.
    Tiselius HG. Epidemiology and medical management of stone disease. BJU Int. 2003;91(8):758-67.
    Tiselius, H. G. (2003). Epidemiology and medical management of stone disease. BJU International, 91(8), pp. 758-67.
    Tiselius HG. Epidemiology and Medical Management of Stone Disease. BJU Int. 2003;91(8):758-67. PubMed PMID: 12709088.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Epidemiology and medical management of stone disease. A1 - Tiselius,H-G, PY - 2003/4/24/pubmed PY - 2003/7/8/medline PY - 2003/4/24/entrez SP - 758 EP - 67 JF - BJU international JO - BJU Int. VL - 91 IS - 8 N2 - Recurrent stone formation in the urinary tract is a common and important problem that must be considered in daily urological practice. With a prevalence of> 10% and an expected recurrence rate of approximately 50%, stone disease has an important effect on the healthcare system. It is generally agreed that patients with uric acid/urate, cystine or infection stones always should be treated pharmacologically. For calcium stone formers the treatment should be chosen according to the severity of the disease. Recurrence in patients with calcium-stone disease can be prevented with general or specific dietary and drinking advice, and with pharmacological therapy. For idiopathic calcium stone formers the most convincing therapeutic effects have been reported with thiazide and alkaline citrate. SN - 1464-4096 UR - https://www.unboundmedicine.com/medline/citation/12709088/Epidemiology_and_medical_management_of_stone_disease_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1464-4096&date=2003&volume=91&issue=8&spage=758 DB - PRIME DP - Unbound Medicine ER -